Table 4.
Etiology distribution in paraneoplastic syndromes patients.
| PNS | ALD | HBV | HCV | Mixed Etiology | MASLD |
|---|---|---|---|---|---|
| PNS (+), n (%) | 22 (22.7%) | 27 (27.8%) | 32 (33%) | 3 (3.1%) | 13 (13.4%) |
| PNS (−), n (%) | 51 (18.1%) | 48 (17.1%) | 131 (46.6%) | 21 (7.5%) | 30 (10.7%) |
| PNS group | |||||
| Hypoglycemia | 7 (31.8%) | 4 (14.8%) | 9 (28.1%) | 2 (66.7%) | 4 (30.8%) |
| Hypercholesterolemia | 10 (45.5%) | 14 (51.8%) | 12 (37.5%) | 1 (33.3) | 4 (30.8%) |
| Thrombocytosis | 3 (13.6%) | 3 (11.2%) | 4 (12.5%) | 0 | 3 (23.1%) |
| Erythrocytosis | 2 (9.1%) | 6 (22.2%) | 7 (21.9%) | 0 | 2 (15.3%) |
Data are presented as a number and percentage; PNS—paraneoplastic syndrome, ALD—alcoholic liver disease, HBV—B virus hepatitis, HCV—C virus hepatitis, MASLD—metabolic dysfunction-associated steatotic liver disease.